Medline to start trading at $29
By HME News Staff
Updated 11:26 AM CST, Thu December 18, 2025
NORTHFIELD, Ill. – Medline Inc. on Dec. 17 was expected to begin trading shares on the Nasdaq Global Select Market under the symbol “MDLN” at an initial public offering of $29 per share. The upsized IPO is for 216,034,482 shares of its Class A common stock; Medline has granted the underwriters a 30-day option to purchase up to an additional 32,405,172 shares of Class A common stock. The company plans to use the proceeds (net of underwriting discounts) from the issuance of 179,000,000 shares to repay outstanding indebtedness under its senior secured term loan facilities and the remainder for general corporate purposes and to bear the expenses of the offering. Medline has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) related to a proposed public offering of its common stock. Medline initially filed for the IPO in November. The company was founded by brothers Jon and Jim Mills in 1966 and was later led by Andy Mills, president, and Charlie Mills, CEO, beginning in 1997. Medline formed a strategic partnership with Blackstone, Carlyle and Hellman & Friedman in 2021, and appointed Jim Boyle CEO and Jim Pigott as COO in 2023. The company was previously a publicly traded company from 1972-77.
Comments